Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Abcuro’s mission is to develop a new class of immune modulatory bio-therapeutics for treating both autoimmunity and cancer. We leverage the systematic target validation and clinical insights gained by its founders to identify new targets. Our intensive use of bioinformatics to interrogate the transcriptome of human disease together with ex-vivo validation in diseased tissue has uncovered new approaches to target key compartm...
Abcuro’s mission is to develop a new class of immune modulatory bio-therapeutics for treating both autoimmunity and cancer. We leverage the systematic target validation and clinical insights gained by its founders to identify new targets. Our intensive use of bioinformatics to interrogate the transcriptome of human disease together with ex-vivo validation in diseased tissue has uncovered new approaches to target key compartments of the immune system.

List your booth number for exhibitions, ask us